Improving the management of sickle cell anaemia in Madagascar
The project will be carried out in Toamasina, the Antananarivo area located in Madagascar with the aim of improving the management of sickle cell disease in Madagascar.
This form of anaemia has two types; the milder which has a prevalence between 10% and 18%, and the most severe form with a prevalence of 1.2%. Sickle cell disease is a public health problem, leading to hospitalisations that may cost up to $21 per day (18.40 euros). Up until now, the universal social cover system is not included within state health policy.
- Organising information and detection campaigns in the three regions where the project will be implemented.
- Installing specific reference and training software for the use of physicians.
- Informative therapies on the disease through performing activities such as travelling photographic exhibitions.